- Home
- IPM vs DYAI Comparison
IPM vs DYAI Comparison
Compare IPM & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPM
- DYAI
- Stock Information
- Founded
- IPM 2005
- DYAI 1979
- Country
- IPM United States
- DYAI United States
- Employees
- IPM N/A
- DYAI N/A
- Industry
- IPM
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IPM
- DYAI Health Care
- Exchange
- IPM NYSE
- DYAI Nasdaq
- Market Cap
- IPM 27.9M
- DYAI 28.3M
- IPO Year
- IPM N/A
- DYAI 2004
- Fundamental
- Price
- IPM $2.03
- DYAI $0.97
- Analyst Decision
- IPM Strong Buy
- DYAI Strong Buy
- Analyst Count
- IPM 1
- DYAI 1
- Target Price
- IPM $6.00
- DYAI $6.00
- AVG Volume (30 Days)
- IPM 36.1K
- DYAI 63.9K
- Earning Date
- IPM 08-13-2025
- DYAI 08-12-2025
- Dividend Yield
- IPM N/A
- DYAI N/A
- EPS Growth
- IPM N/A
- DYAI N/A
- EPS
- IPM N/A
- DYAI N/A
- Revenue
- IPM $6,344,746.00
- DYAI $3,554,344.00
- Revenue This Year
- IPM $1,957.49
- DYAI $22.56
- Revenue Next Year
- IPM $17.96
- DYAI $30.95
- P/E Ratio
- IPM N/A
- DYAI N/A
- Revenue Growth
- IPM 14.16
- DYAI 57.59
- 52 Week Low
- IPM $1.52
- DYAI $0.91
- 52 Week High
- IPM $5.50
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- IPM N/A
- DYAI 53.08
- Support Level
- IPM N/A
- DYAI $0.91
- Resistance Level
- IPM N/A
- DYAI $0.99
- Average True Range (ATR)
- IPM 0.00
- DYAI 0.06
- MACD
- IPM 0.00
- DYAI 0.01
- Stochastic Oscillator
- IPM 0.00
- DYAI 59.93
About IPM INTELLIGENT PROTECTION MANAGEMENT
Intelligent Protection Management Corp is a communications software innovator that powers multimedia social applications.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.